Atlas Trials

Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.

Clinical trial NCT01624038 · UNKNOWN

Trial details

NCT number
NCT01624038
Sponsor
Ain Shams University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Thalassemia Intermedia
Start date
2012-06-01
Primary completion
2012-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.